Updates on innovations in #cancer research, prevention, care, and education from the Herbert Irving Comprehensive Cancer Center at @columbiamed/@nyphospital.
New York, NY
Joined October 2013
- Tweets5.9K
- Following1.1K
- Followers4.8K
- Likes4.6K
Pinned Tweet
Proud to announce that HICCC at @columbiamed / @nyphospital has once again earned the NCI’s Comprehensive Cancer Center designation with a $27M, five-year renewal supporting research, clinical trials, education, and community outreach at @Columbia cancer.columbia.edu/news/her…
Congratulations @DrDawnHershman on receiving the 2026 Potamkin Prize for Research from @PBCC! Dr. Hershman accepted the award at the PA Breast Cancer Coalition’s annual conference, honoring leaders in breast cancer research, advocacy, treatment, and education. 👏🩷 @ColumbiaMed
Herbert Irving Comprehensive Cancer Center retweeted
From #CellCoast2026: Sophie Hanina, MD, PhD (@SophieHanina), of @columbiacancer joins Marco Davila, MD, PhD, of @RoswellPark to discuss sensitive HLA-independent T-cell receptors designed to overcome tumor antigen heterogeneity in solid tumors.
Herbert Irving Comprehensive Cancer Center retweeted
Congratulations to our 2026 Equity in Access Research Program grantees!
Melissa Beauchemin, PhD, Assistant Professor of Nursing (Principal Investigator): @Columbia
Justine Kahn, MD, MS, Associate Professor of Pediatrics (Co-Principal Investigator): @columbiacancer
Barbara Pro, MD, Professor of Medicine, Hematology and Oncology (Co-Principal Investigator): @columbiacancer
Herbert Irving Comprehensive Cancer Center retweeted
Cachexia affects many people with advanced cancer and is a major contributor to cancer-related illness and death. Now, researchers at @columbiacancer have identified an unexpected molecular pathway in fat cells that helps drive this condition. columbiamed.link/4hvJvtI
Herbert Irving Comprehensive Cancer Center retweeted
Congratulations to 2026 Pershing Square Sohn Prize winners Santiago Correa of @columbiacancer and @jessicacstark of @MIT on receiving the NIH Director’s New Innovator Award. We are proud to support their work and look forward to what comes next!
The NIH Director’s New Innovator Award supports exceptionally creative early-career investigators pursuing innovative research with the potential for significant impact.
Learn about the 2026 award recipients and their groundbreaking projects: commonfund.nih.gov/newinnova…
ALT Three images are shown showing lab equipment, a scientist, and neurons. The NIH Common Fund logo is also shown. Text reads: “Awards Announcement NIH Director’s New Innovator Award”
Herbert Irving Comprehensive Cancer Center retweeted
Congratulations to 2021 Pershing Square Sohn Prize winner Christine Chio, PhD (@chiolaboratory) of @columbiacancer on her new @NatureCancer paper! Building on the methionine research her prize supported, her lab now reveals how iron drives cancer cachexia: cancer.columbia.edu/news/how…
Herbert Irving Comprehensive Cancer Center retweeted
Congratulations to IICD Postdoctoral Research Scientist @shi_lingting on being named a 2026 @statnews Wunderkind! 🎉
Lingting uses single-cell and spatial genomics and computational methods to study cancer immunology.
🔗cancerdynamics.columbia.edu/…
#STATWunderkind #CancerResearch
ALT STAT Wunderkinds '26 award presented to Dr. Lingting Shi, a Postdoctoral Research Scientist with the IICD.
Herbert Irving Comprehensive Cancer Center retweeted
In this interview with Larisa J. Geskin, MD, of @columbiacancer, explore how inflammation, tumor biology, immune status and quality-of-life goals are shaping a more individualized approach to cutaneous #lymphoma care.
▶️ buff.ly/AMjopAE
Researchers from @ColumbiaMed studying cancer cachexia, a serious condition causing extreme weight loss in 50%-80% of cancer patients, have found a potential driver of the disease: iron accumulation in fat cells. Read the new study from @Chiolaboratory
cancer.columbia.edu/news/how…
Meet HICCC new member Dr. Liora Schultz, director of @ColumbiaMed’s Pediatric Cellular Immunotherapy Program, and her research advancing cell therapy as a more durable alternative to years of toxic chemotherapy for children with leukemia. cancer.columbia.edu/news/lio…
Herbert Irving Comprehensive Cancer Center retweeted
From fixed-duration combinations to continuous BTK inhibition, evolving #CLL options are reshaping treatment selection and sequencing across lines of therapy.
💬 Nicole Lamanna, MD, of @columbiacancer, discusses the latest in CLL at #SOHO2026.
➡️ Watch here: buff.ly/DZb4kvw
Herbert Irving Comprehensive Cancer Center retweeted
🔬 New research from IICD and @columbiamed!
Published in @NatureImmunol, the study tracks T-cell clones across time and tissue to reveal how they evolve and contribute to damage in graft-versus-host disease (GVHD). #CancerResearch #Immunology
Read more: cancerdynamics.columbia.edu/…
ALT Figure illustrating “Spatiotemporal single-cell profiling reveals T cell clonal dynamics and phenotypic plasticity in human graft-versus-host disease,” including computational methods
Herbert Irving Comprehensive Cancer Center retweeted
Excited to share our new preprint! 🎉
Using base-editor screens, we reveal how individual residues within the intrinsically disordered region of YTHDF2 control protein interactions, condensate recruitment, and m⁶A-dependent mRNA decay.
biorxiv.org/content/10.64898…
🧵👇
Herbert Irving Comprehensive Cancer Center retweeted
A little blue from our @ColumbiaUrology team for Prostate Cancer Awareness Month 💙
About 1 in 8 men will be diagnosed with prostate cancer, but risk is not evenly shared. Age, family history, background, and inherited genetic changes can all shape when screening enters the picture.
A PSA blood test can be an important tool, but a number alone never tells the whole story. Learn more: columbiadoctors.org/specialt…
Herbert Irving Comprehensive Cancer Center retweeted
Dr. Suzanne Lentzsch (@columbiacancer) opens Advances in AL Amyloidosis: current concepts in diagnosis & initial therapy.
Fri, Oct 30 · 8:25am–12:30pm ET · Virtual · 4.0 credits
Register: buff.ly/orLJ7S0
Full agenda below 👇
#Amyloidosis #Hematology
Herbert Irving Comprehensive Cancer Center retweeted
Enjoyed speaking with @GIOncologyNow about my path into GI oncology, translating discoveries from the lab into clinical trials, and what marathon running has taught me about patience, resilience, and progress over time.
gioncologynow.com/post/turni…
Promising early findings in metastatic pancreatic cancer ‼️ a phase 2 study targeting CXCR4 with immunotherapy and chemotherapy showed encouraging outcomes—including a complete response in one patient who remains cancer-free today. @BizarMd @DrGManji cancer.columbia.edu/news/new…
Congratulations to @ColumbiaMed's @AmericanCancer 2026 grantees accelerating our understanding of cancer - from prevention and risk assessment to understanding tumor progression, metastasis, treatment resistance and new therapeutic approaches. 👏🧪 cancer.org/content/dam/cance…
Herbert Irving Comprehensive Cancer Center retweeted
Hear Timothy Wang @columbiacancer discuss how nerve-cancer connections orchestrate the tumor microenvironment in gastrointestinal tumors @CellPressEvents #CSHallmarks2026
Early bird registration closes September 4!
hubs.ly/Q04v9bPY0
Herbert Irving Comprehensive Cancer Center retweeted
A new treatment for advanced pancreatic cancer nearly doubled survival in patients in a clinical trial. @ColumbiaCancer researchers were part of its development: cancer.columbia.edu/news/col… @ColumbiaMed
